Changes between two versions
What changed between the resolution motion and the adopted text
From · resolution motion· 9 Dec 2020
on the draft Commission implementing decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified maize MON 88017 (MON-88Ø17-3) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council
The two versions differ only in presentation: cover page, numbering, or the parts a report carries that the adopted text does not.
+4 added · −3 removed · 0 changed paragraphs, packaging included.
Part 2 of 2: Paragraphs 61–68
8 unchanged paragraphs
7. Reiterates its call on the Commission to stop authorising GMOs, whether for cultivation or for food and feed uses, when no opinion is delivered by Member States in the Appeal Committee, in accordance with Article 6(3) of Regulation (EU) No 182/2011;
8. Reiterates its call on the Commission not to authorise herbicide-tolerant GM crops until the health risks associated with the residues have been comprehensively investigated on a case-by-case basis, which requires a full assessment of the residues from spraying such GM crops with complementary herbicides, an assessment of the herbicide break-down products and any combinatorial effects, including with the GM plant itself;
9. Calls on EFSA to finally accept the substantial differences between native Bt toxins and those expressed by synthetic transgenes in GM crop plants, and to widen its risk assessment in order to fully take into account all interactions and combinatorial effects between Bt toxins, GM plants and their constituents, residues from spraying with the complementary herbicides, the environment as well as impacts on health and food safety;
10. Calls on EFSA to no longer accept toxicity studies based on isolated proteins which are likely to be different in structure and biological effects compared to those produced by the plant itself, and to require that all tests are carried out with tissue from the GM plant;
11. Calls on EFSA to make sure that data from field trials or green houses cover a sufficiently broad range of agronomic and environmental conditions to assess the impact of all stress factors which have to be expected during cultivation on gene expression and plant composition;
12. Calls on EFSA to make sure that the data from field trials or green houses cover a sufficiently broad range of different varieties to assess the impact of various genetic backgrounds on gene expression and plant composition;
13. Calls on EFSA to request data on the impact of the consumption of food and feed derived from GM plants on the intestinal microbiome;
14. Instructs its President to forward this resolution to the Council and the Commission, and to the governments and parliaments of the Member States.